Lantus Injection 100iu Vial

Lantus Injection 100IU Vial contains Insulin Glargine as its active ingredient. Insulin Glargine is a long-acting basal insulin analogue used in the management of diabetes mellitus. It provides a steady release of insulin over a prolonged period, helping to regulate blood sugar levels throughout the day and night.

Ingredients:

• Insulin Glargine: Insulin Glargine is a recombinant human insulin analogue that is modified to have a prolonged duration of action. It forms microprecipitates at the injection site, allowing for a slow and continuous release of insulin into the bloodstream.

Uses:

1. Diabetes Mellitus: Lantus Injection 100IU Vial is indicated for the treatment of diabetes mellitus in adults and pediatric patients. It helps to control blood glucose levels by providing a basal level of insulin activity, thereby reducing the risk of hyperglycemia (high blood sugar) and its associated complications.
2. Type 1 Diabetes: It may be used in patients with type 1 diabetes mellitus as part of a comprehensive treatment regimen that includes mealtime insulin (rapid-acting or short-acting) to cover postprandial glucose excursions.

Side Effects:

1. Hypoglycemia: The most common side effect of insulin therapy, including Insulin Glargine, is hypoglycemia (low blood sugar). Symptoms may include sweating, shakiness, confusion, dizziness, hunger, and palpitations. Severe hypoglycemia may lead to unconsciousness or seizures and requires prompt treatment with glucose or glucagon.
2. Injection Site Reactions: Localized reactions at the injection site, such as pain, redness, or swelling, may occur. These reactions are usually mild and resolve on their own.
3. Weight Gain: Some patients may experience weight gain with insulin therapy, particularly when blood glucose levels are well-controlled.
4. Allergic Reactions: Rarely, allergic reactions to insulin, including Insulin Glargine, may occur. Symptoms may include rash, itching, difficulty breathing, or swelling of the face, lips, or tongue. Immediate medical attention is necessary if an allergic reaction is suspected.

Precautions:

1. Hypoglycemia Risk: Patients using Lantus Injection 100IU Vial should be educated about the signs and symptoms of hypoglycemia and how to treat it. Blood glucose monitoring and dose adjustments may be necessary to minimize the risk of hypoglycemia.
2. Renal or Hepatic Impairment: Use with caution in patients with renal or hepatic impairment, as insulin requirements may be altered in these populations.
3. Pregnancy and Breastfeeding: Insulin Glargine can be used during pregnancy and breastfeeding under the supervision of a healthcare professional. Close monitoring of blood glucose levels is essential to maintain optimal glycemic control.
4. Driving and Operating Machinery: Patients should be advised to monitor their blood glucose levels regularly, especially before driving or operating machinery, to prevent hypoglycemia-related accidents.

When Not to Use:

Lantus Injection 100IU Vial should not be used in patients with hypersensitivity to Insulin Glargine or any of the excipients in the formulation. It should also not be used during episodes of hypoglycemia or in patients with diabetic ketoacidosis.

FAQ:

1. How should Lantus Injection 100IU Vial be administered?
   • Lantus Injection 100IU Vial is administered subcutaneously (under the skin) once daily, preferably at the same time each day. The injection site should be rotated to prevent lipodystrophy (changes in fat tissue) and injection site reactions.
2. What should I do if I miss a dose of Lantus Injection 100IU Vial?
   • If a dose is missed, it should be administered as soon as possible, unless it is almost time for the next scheduled dose. Patients should not double the dose to make up for a missed injection.
3. How should Lantus Injection 100IU Vial be stored?
   • Lantus Injection 100IU Vial should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) until the expiration date printed on the label. Once in use, the vial can be kept at room temperature (below 86°F or 30°C) for up to 28 days.
4. Can Lantus Injection 100IU Vial be used in children?
   • Lantus Injection 100IU Vial is approved for use in pediatric patients with diabetes mellitus, under the supervision of a healthcare professional. Dosage adjustments may be necessary based on age, weight, and individual insulin requirements.
5. Is Lantus Injection 100IU Vial covered by insurance?
   • Lantus Injection 100IU Vial may be covered by insurance plans, but coverage may vary depending on the specific insurance provider and policy. Patients should check with their insurance company regarding coverage and any potential copayments or out-of-pocket expenses.